jeudi 31 mai 2018

Hemp, Inc. Announces Creation of Proprietary Industrial Hemp Strains as U.S. Senate Supports Cannabis Seed Bank

CV Sciences, Inc. Supports World No Tobacco Day on May 31, 2018

jeudi 24 mai 2018

Global Critical Care Diagnostics Market Growth, Trends, and Forecasts 2018-2023: CAGR to Grow at 6% - ResearchAndMarkets.com | Business Wire

Global Critical Care Diagnostics Market Growth, Trends, and Forecasts 2018-2023: CAGR to Grow at 6% - ResearchAndMarkets.com | Business Wire: The

mercredi 23 mai 2018

ResMed-Studien zeigen, dass Fernüberwachung und automatisierte Nachversorgung Therapietreue bei PAP-Therapie verbessern | Business Wire

ResMed-Studien zeigen, dass Fernüberwachung und automatisierte Nachversorgung Therapietreue bei PAP-Therapie verbessern | Business Wire: Ferngesteuerte Patientenüberwachungs- und Nachschubprogramme verbessern nachweislich die Therapietreue von Patienten mit positivem Atemwegsdruck (PAP)

Allscripts Sunrise™ powers The Dudley Group NHS Foundation Trust to transform delivery of care

Allscripts Sunrise™ powers The Dudley Group NHS Foundation Trust to transform delivery of care: One of the country’s largest teaching hospitals leads the way in connecting the health economy in U.K. and provides tools to increase efficiency in an era of ever greater demand

Shire plc : Rule 2.9 Announcement

Spiolto® Respimat® enables greater physical activity in people living with Chronic Obstructive Pulmonary Disease | Business Wire

Spiolto® Respimat® enables greater physical activity in people living with Chronic Obstructive Pulmonary Disease | Business Wire: Tiotropium/olodaterol Respimat® enables greater physical activity in people living with Chronic Obstructive Pulmonary Disease

lundi 21 mai 2018

Janssen presentará nuevos datos sobre cánceres urotelial, hematológico y de próstata en la ASCO 2018, incluidas las selecciones de lo mejor de la ASCO | Business Wire

Janssen presentará nuevos datos sobre cánceres urotelial, hematológico y de próstata en la ASCO 2018, incluidas las selecciones de lo mejor de la ASCO | Business Wire: Las empresas farmacéuticas Janssen de Johnson & Johnson han anunciado hoy que se presentarán 21 resúmenes patrocinados por la empresa en la Reunió

Dr. Martin T. Rothman devient Venture Partner de Sofinnova Partners | Business Wire

Dr. Martin T. Rothman devient Venture Partner de Sofinnova Partners | Business Wire: Sofinnova Partners appoints internationally renowned physician and entrepreneur, Dr. Martin T. Rothman, as Venture Partner.

UTILITY Receives Qualified Infectious Disease Product Designation from the U.S. FDA | Business Wire

UTILITY Receives Qualified Infectious Disease Product Designation from the U.S. FDA | Business Wire: UTILITY therapeutics Ltd (“UTILITY” or “the Company”), a pharmaceutical company focused on developing and commercialising antibiotics in the US, today

samedi 19 mai 2018

Takeda présentera son vaste portefeuille en oncologie et ses données préliminaires lors de l'assemblée de l'American Society of Clinical Oncology (ASCO) et du congrès de l'European Hematology Association (EHA) | Business Wire

Takeda présentera son vaste portefeuille en oncologie et ses données préliminaires lors de l'assemblée de l'American Society of Clinical Oncology (ASCO) et du congrès de l'European Hematology Association (EHA) | Business Wire: Takeda Pharmaceutical Company Limited (TSE: 4502) a annoncé aujourd'hui que la société présentera un total de 14 présentations sponsorisées par Takeda

vendredi 18 mai 2018

Oncodesign Announces Publication of an Abstract for the 54th ASCO Annual Meeting in Chicago | Business Wire

Oncodesign Announces Publication of an Abstract for the 54th ASCO Annual Meeting in Chicago | Business Wire: Regulatory News: ONCODESIGN (Paris:ALONC) (ALONC – FR0011766229), a biopharmaceutical company specializing in precision medicine, announces the public

Cathryn Tames Receives the Rite Aid Foundation’s KIDCHAMPSM Award | Business Wire

Cathryn Tames Receives the Rite Aid Foundation’s KIDCHAMPSM Award | Business Wire: The Rite Aid Foundation announced today that Cathryn Tames, Executive Director of the Children’s Developmental Center in Richland, Washington, has bee

Resumen: BioClin Therapeutics, Inc. anuncia la presentación del póster de B-701 en la edición 2018 de la reunión anual de la Sociedad Estadounidense de Oncología Clínica (ASCO) | Business Wire

Resumen: BioClin Therapeutics, Inc. anuncia la presentación del póster de B-701 en la edición 2018 de la reunión anual de la Sociedad Estadounidense de Oncología Clínica (ASCO) | Business Wire: BioClin Therapeutics, Inc., una compañía dedicada al desarrollo de fármacos clínicos, ha anunciado hoy que los datos derivados de su estudio en curso

Samenvatting: Takeda belicht breed Oncologie-Portfolio en Pipeline Data tijdens de jaarlijkse bijeenkomsten van de American Society of Clinical Oncology (ASCO) en het congres van de European Hematology Association (EHA) | Business Wire

Samenvatting: Takeda belicht breed Oncologie-Portfolio en Pipeline Data tijdens de jaarlijkse bijeenkomsten van de American Society of Clinical Oncology (ASCO) en het congres van de European Hematology Association (EHA) | Business Wire: Takeda Pharmaceutical Company Limited (TSE: 4502) kondigde vandaag aan dat het bedrijf in totaal 14 door Takeda Oncology-gesponsorde presentaties zal

NeoTract Announces American Urological Association (AUA) Recommendation of UroLift® System as a Standard of Care Option for the Treatment of Enlarged Prostate | Business Wire

NeoTract Announces American Urological Association (AUA) Recommendation of UroLift® System as a Standard of Care Option for the Treatment of Enlarged Prostate | Business Wire: NeoTract Announces American Urological Association Recommendation of UroLift® System as a Standard of Care Option for Enlarged Prostate Treatment

jeudi 17 mai 2018

EURONEXT 457SX

TURBO ILLIMITÉ CALL SUR EURONEXT (457SZ)

Temps réel - 17/05 17:23:19
0.59	EUR		+8.26%

Temps réel - 17/05 17:23:19
0.59	EUR		+8.26%

Protalex Announces Presentation Highlighting PRTX-100 Phase 1b Clinical Data in Patients with Immune Thrombocytopenia at the European Hematology Association 23rd Annual Meeting | Business Wire

Protalex Announces Presentation Highlighting PRTX-100 Phase 1b Clinical Data in Patients with Immune Thrombocytopenia at the European Hematology Association 23rd Annual Meeting | Business Wire: Protalex, Inc. (OTCQB: PRTX), a clinical-stage biopharmaceutical company, today announced that preliminary results from its European Phase 1b open-lab

Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2018 Annual Meeting | Business Wire

Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2018 Annual Meeting | Business Wire: Flatiron Health today announced 11 abstracts accepted for presentation at the 2018 American Society for Clinical Oncology (ASCO) Annual Meeting, which

LYRICA® (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint | Business Wire

LYRICA® (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint | Business Wire: Pfizer Inc. (NYSE: PFE) announced today positive top-line results of a Phase 3 study examining the use of LYRICA® (pregabalin) Oral Solution CV as adj

Bellicum Announces Clinical Presentations on Lead Product Candidate BPX-501 at the 23rd Congress of the European Hematology Association

Bellicum Announces Clinical Presentations on Lead Product Candidate BPX-501 at the 23rd Congress of the European Hematology Association: Oral and poster presentations highlight BPX-501 data in pediatric patients with PIDs and AML

Pierre Fabre and Array BioPharma Announce COLUMBUS Phase 3 Study Overall Survival Results in BRAF-Mutant Melanoma Will Be Presented at 2018 ASCO Annual Meeting | Business Wire

Pierre Fabre and Array BioPharma Announce COLUMBUS Phase 3 Study Overall Survival Results in BRAF-Mutant Melanoma Will Be Presented at 2018 ASCO Annual Meeting | Business Wire: Pierre Fabre with its partner Array BioPharma Inc. will present overall survival (OS) data from its late-stage candidates encorafenib, a BRAF inhibito

Exelixis’ Partner Ipsen Announces European Commission Approval of CABOMETYX® (Cabozantinib) for Previously Untreated Intermediate- or Poor-Risk Advanced Renal Cell Carcinoma | Business Wire

Exelixis’ Partner Ipsen Announces European Commission Approval of CABOMETYX® (Cabozantinib) for Previously Untreated Intermediate- or Poor-Risk Advanced Renal Cell Carcinoma | Business Wire: Exelixis, Inc. (Nasdaq:EXEL) today announced that its partner Ipsen received approval from the European Commission (EC) for CABOMETYX® (cabozantinib)

mercredi 16 mai 2018

AHF: Congenital Syphilis Rates a ‘Tragedy’ and L.A. County Does Nothing | Business Wire

AHF: Congenital Syphilis Rates a ‘Tragedy’ and L.A. County Does Nothing | Business Wire: AHF: Congenital Syphilis Rates a ‘Tragedy’ and L.A. County Does Nothing

Viz.ai to Present Expanded Data on ALADIN and New Data on ADVANCE Expanding Its Stroke Pipeline at the 2018 ESOC | Business Wire

Viz.ai to Present Expanded Data on ALADIN and New Data on ADVANCE Expanding Its Stroke Pipeline at the 2018 ESOC | Business Wire: Viz.ai, an applied artificial intelligence healthcare co, to present expanded ALADIN and new ADVANCE data expanding its stroke pipeline at ESOC 2018

Celgene to Present New Clinical Data in Blood Cancer and Solid Tumor Therapies at Upcoming American Society of Clinical Oncology (ASCO) Scientific Sessions | Business Wire

Celgene to Present New Clinical Data in Blood Cancer and Solid Tumor Therapies at Upcoming American Society of Clinical Oncology (ASCO) Scientific Sessions | Business Wire: Celgene to Present New Clinical Data at ASCO 2018 highlighting the value of innovative research in key blood cancer and solid tumor disease areas

Minomic Completes Prospective Clinical Study Using MiCheck® to Assist in Diagnosis of Prostate Cancer | Business Wire

Minomic Completes Prospective Clinical Study Using MiCheck® to Assist in Diagnosis of Prostate Cancer | Business Wire: Minomic International Ltd announced the completion of its Prospective Clinical Trial of the company's novel prostate cancer diagnostic test, MiCheck®.

Vitrisa Therapeutics Acquires Rights to MAKO Clinical Trial Data in wAMD | Business Wire

Vitrisa Therapeutics Acquires Rights to MAKO Clinical Trial Data in wAMD | Business Wire: Vitrisa Therapeutics, Inc., a Company focused on developing a suite of platform technologies optimized for ocular therapeutics and an associated pipel

Medtronic Begins U.S. Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients with Coronary Artery Disease

vôtre suivi ce jour merci

Entrée	Pages vues
France	381
Italie	182
États-Unis	25
Allemagne	9
Pologne	9
Ukraine	5
Algérie	4
Portugal	4
Irlande	2
Islande	2

merci pour vôtre suivi

Pages vues aujourd'hui

Pages vues hier

107

Pages vues le mois dernier

3 669

Historique global des pages vues

243 216

Clovis Oncology Announces Presentations at 2018 ASCO Annual Meeting | Business Wire

Clovis Oncology Announces Presentations at 2018 ASCO Annual Meeting | Business Wire: Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that seven abstracts highlighting progress in the Rubraca preclinical research and clinical devel

PharmaCyte Biotech Successfully Completes 29 Tests Conducted on Live Cells Used in Pancreatic Cancer Therapy | Business Wire

PharmaCyte Biotech Successfully Completes 29 Tests Conducted on Live Cells Used in Pancreatic Cancer Therapy | Business Wire: PharmaCyte Biotech announces successful completion of 29 tests conducted on live cells used in pancreatic cancer therapy.

Myonexus Therapeutics Receives FDA Rare Pediatric Drug Designation for Pioneering Treatment of Limb Girdle Muscular Dystrophy Type 2E | Business Wire

Myonexus Therapeutics Receives FDA Rare Pediatric Drug Designation for Pioneering Treatment of Limb Girdle Muscular Dystrophy Type 2E | Business Wire: Myonexus Therapeutics receives FDA Rare Pediatric Drug Designation for pioneering gene therapy treatment of limb girdle muscular dystrophy type 2E.

Scientist.com and Brain and Spine Institute’s Bioincubator, iPEPS, Launch Biotech Startup Competition for Companies Accelerating CNS Disease Research | Business Wire

Scientist.com and Brain and Spine Institute’s Bioincubator, iPEPS, Launch Biotech Startup Competition for Companies Accelerating CNS Disease Research | Business Wire: Scientist.com, the life science industry’s leading online marketplace for outsourced research, and The Brain and Spine Institute incubator, iPEPS-ICM,

Kommuniké från årsstämman i LIDDS

Oxford Immunotec to Present at the 2018 UBS Global Healthcare Conference

vendredi 11 mai 2018

recommandations

Bourse de Paris : Le point sur les changements de recommandations à Paris

11/05/2018 | 07:55

    PARIS, 11 mai (Reuters) - Principaux changements de recommandations et/ou d'objectifs de
cours enregistrés vendredi à Paris.
    
    * SOLUTIONS 30 SE            - Berenberg abaisse sa recommandation à "conserver" contre
"acheter" et relève l'objectif de cours à 42,50 euros contre 38,50 euros.
    
    SAFE ORTHOPAEDICS SA            - Midcap Partners entame son suivi avec une recomandation
"neutre" et un objectif de cours à 0,55%.

    * AIR FRANCE-KLM           - HSBC abaisse l'objectif de cours à 9,5 euros contre 13 euros.

jeudi 10 mai 2018

MyDx Secures City and State Legal Cannabis Manufacturing and Distribution for Its MyDx360 Customers

Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2018

Veritas Pharma Provides Comment on Canadian Senate Recommendation for a One-Year Deferment Legalizing Cannabis

mercredi 9 mai 2018

GENFIT : ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 15, 2018 - AVAILABILITY OF PREPARATORY DOCUMENTS

Photocure ASA: Annual general meeting held

Intrommune Therapeutics Announces Crowdfunding Financing Campaign to Support Food Allergy Treatment Research

mardi 8 mai 2018

bonne soirée

Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore

Reata Pharmaceuticals, Inc. Announces First Quarter 2018 Financial Results and an Update on Development Programs

Tempus Announces New Initiative to Support Physicians Efforts to Deliver Personalized Medicine

CV Sciences, Inc. to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018

Abeona Therapeutics Announces Upcoming Presentations

Abeona Therapeutics Announces Upcoming Presentations: Presentations at the American Society of Gene and Cell Therapy Conference and the International Investigative Dermatology Conference

Cyclacel Pharmaceuticals to Release First Quarter 2018 Financial Results

lundi 7 mai 2018

MediciNova Announces Plans to Collaborate with UCLA Researchers in Grant-Funded Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder and Withdrawal

PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share

Nymox Announces Relocation of Company Headquarters to Switzerland

Ambu A/S: Interim report for Q2 2017/18 and for the half-year (1 October 2017- 31 March 2018)

OSE Immunotherapeutics Presents New Data on OSE-127 at the American Association of Immunologists (AAI) Annual Meeting May 4-8 2018 in Austin, Texas

BeiGene to Present at the Deutsche Bank 43rd Annual Health Care Conference

Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally

Veritas Pharma Establishes New Subsidiary in Puerto Rico, USA

dimanche 6 mai 2018

bonjour, mon préféré

Métier

Marathon Oil Corporation est spécialisé dans l'exploration et la production de pétrole et de gaz naturel. Le CA par famille de produits se répartit comme suit :
- pétrole brut et condensats de gaz (79,5%) : 185 000 barils de pétrole produits par jour en 2017 ;
- gaz naturel (11,7%) : 23,6 millions de m3 produits par jour ;
- gaz naturel liquéfié (7,7%) : 55 000 barils produits par jour ;
- autres (1,1%).
La répartition géographique du CA est la suivante : Etats-Unis (70,6%), Guinée Equatoriale (12,1%), Libye (9,9%), Royaume Uni (6,6%) et autres (0,8%).
En mai 2017, le groupe a cédé l'activité extraction, transformation et transport de sables pétrolifères (Canada).

Nombre d'employés : 2 300 personnes.

vendredi 4 mai 2018

CellaVision AB: Kommuniké från årsstämma i CellaVision AB (publ) den 4 maj 2018

Novo Nordisk A/S purchases B shares worth DKK 1,038 million from Novo Holdings A/S under the 2018 share repurchase programme

Align Technology Opens Invisalign® Treatment Planning and Training Facility in Germany

Align Technology Opens Invisalign® Treatment Planning and Training Facility in Germany: Investment Reflects Large, Untapped Market Opportunity for Clear Aligners and Commitment to the Region

Nicox : Point d'activité du premier trimestre 2018 et résultats financiers

mercredi 2 mai 2018

Sandoz receives complete response letter from the US FDA for proposed biosimilar rituximab

Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections

Global Female Contraceptives Market to 2023 - CAGR Expected to Grow at 8.5% During the Forecast Period - ResearchAndMarkets.com | Business Wire

Global Female Contraceptives Market to 2023 - CAGR Expected to Grow at 8.5% During the Forecast Period - ResearchAndMarkets.com | Business Wire: The

recommandation

Bourse de Paris : Le point sur les changements de recommandations à Paris

02/05/2018 | 07:41

    PARIS, 2 mai (Reuters) - Principaux changements de recommandations et/ou d'objectifs de
cours enregistrés mercredi à Paris.
    
    * SPIE           - Jefferies entame son suivi avec une recommandation à "sous-performer" et
un objectif de cours à 14,30 euros. Le titre perd 2,19% à 18,32 euros.
    
    * UBISOFT           - KeyBanc reprend sa couverture avec un conseil à "surpondérer" et un
objectif de cours à 94 euros. Le titre gagne 3,96% à 82,4 euros.
    
    * AIRBUS GROUP          - Berenberg relève son objectif de cours à 120 euros contre 96
euros. 
    
    * AKKA          - Portzamparc abaisse sa recommandation à "conserver" contre "acheter" et
revoit son objectif de cours à 60,4 euros contre 61,2 euros. Le titre perd 2,93% à 56,3 euros.
    
    * INFOTEL           - Portzamparc relève sa recommandation à "acheter" contre "renforcer" et
relève son objectif de cours à 62,8 euros contre 61,4 euros. L'action avance de 2,8% à 55 euros.
    
    * GUERBET           - Portzamparc relève sa recommandation à "renforcer" contre "conserver".
Le titre prend 2,67% à 53,9 euros.

    * MADVERTISE            - Midcap Partners abaisse son objectif de cours à 1,6 euro contre
1,8 euro avec un conseil à "acheter" inchangé. L'action chute de 16,13% à 1,17 euros.

 (Service Marchés)

BeiGene Appoints Senior Pharmaceutical Executive Dr. Xiaobin Wu as General Manager of China and President of BeiGene, Ltd.

Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma

Notis från Oasmia Pharmaceutical AB

mardi 1 mai 2018

Cotiviti Announces First Quarter 2018 Results | Business Wire

Cotiviti Announces First Quarter 2018 Results | Business Wire: Cotiviti Holdings, Inc. (NYSE:COTV) (“Cotiviti”), a leading provider of payment accuracy and analytics-driven solutions primarily focused on the healt

Aeterna Zentaris to Announce First Quarter 2018 Financial and Operating Results on May 7, 2018

Harvard Bioscience Subsidiary Multi Channel Systems Launches Beta Cell Screening System for Diabetes Research, Entering New Segment of Electrophysiology Market

Harvard Bioscience Subsidiary Multi Channel Systems Launches Beta Cell Screening System for Diabetes Research, Entering New Segment of Electrophysiology Market: Multi-Electrode Array (MEA) Offers New Route for Type 2 Diabetes Drug Development and Ability to Elucidate Beta Cell Pathophysiology

Sanofi / Regeneron contraint de réduire ses prix suite à la lenteur des ventes | Pharmafile

German High Street Properties A/S – increase due to merger of share classes

German High Street Properties A/S – increase due to merger of share classes: The share capital of German High Street Properties has been increased due to merger of share classes. The admittance to trading and official listing of shares which have been unlisted until now will take effect as per 3 May 2018 in the ISIN below.

MERCI a toutes et tous de suivre mon blog.bonne fête du 1er Mai

Pages vues aujourd'hui

148

Pages vues hier

Pages vues le mois dernier

4 027

Historique global des pages vues

241 498

Frontier Label Designs and Creates Premium Label Experience for Visionary Craft Beer Brewers

Frontier Label Designs and Creates Premium Label Experience for Visionary Craft Beer Brewers: From creative concepts to beautiful labels, Frontier Label simplifies the labeling process for beer companies to attract the attention of customers